IRESS LIMITED — Director's Dealing 2017

Mar 5, 2017

==> picture [546 x 84] intentionally omitted <==

The Manager Company Announcements Office Australian Stock Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000

6 March 2017

Dear Sir or Madam

RE: APPENDIX 3Y – ANDREW WALSH – CEO & MANAGING DIRECTOR

Please find attached an Appendix 3Y announcement relating to the vesting of performance rights granted to Andrew Walsh, CEO & Managing Director.

Yours sincerely

==> picture [142 x 61] intentionally omitted <==

Peter Ferguson Group General Counsel & Company Secretary

IRESS Limited Corporate Office: Level 18, 385 Bourke Street MELBOURNE VIC 3000 Australia

T +61 3 9018 5800 Enquires@iress.com www.iress.com.au

Offices in : Australia, Canada, Hong Kong, New Zealand, Singapore, South Africa and United Kingdom

ABN: 47 060 313 359

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	IRESS Limited
ABN	47 060 313 359

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Walsh
Date of last notice	1 November 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	3 March 2017

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change		Ordinary Shares Direct: 338,423 Indirect: ..32,079 Unvested Share/Rights Grants: 2012 Series Performance Rights 2012:  4 year term, granted 7 May 2012, 3 year measurement period commencing 7 May 2013: - 80,000, 57,600 vested on 7 May 2016,leaving 22,400 subject to retest in Nov 2016,  4 year term, granted 7 May 2012, 4 year measurement period commencing 7 May 2012: - 80,000, 76,960 vested on 7 May 2016,leaving 3,040 subject to retest in Nov 2016 2013 Series Performance Rights 2013:  4 year term, granted 7 May 2013, 3 year measurement period commencing 7 May 2014: - 65,000  4 year term, granted 7 May 2013, 4 year measurement period commencing 7 May 2013: - 65,000 2014 Series Deferred Shares Rights 2014:  3 year term granted 7 May 2014: - 58,000 Performance Rights 2014:  4 year term, granted 7 May 2014, 3 year measurement period commencing 7 May 2015: - 63,000  4 year term, granted 7 May 2014, 4 year measurement period commencing 7 May 2014: - 63,000 2015 Series Deferred Shares Rights 2015:  3 year term granted 7 May 2015: - 55,000 Performance Rights 2015:  4 year term, granted 7 May 2015, 3 year measurement period commencing 7 May 2016: - 60,000  4 year term, granted 7 May 2015, 4 year measurement period commencing 7 May 2015: - 60,000 2016 Series Deferred Shares Rights 2016:  3 year term granted 7 May 2016: - 60,000 Performance Rights 2016:  4 year term, granted 7 May 2016, 3 year measurement period commencing 1 Jan 2017: - 60,000  4 year term, granted 7 May 2016, 4 year measurement period commencing 1 Jan 2016: - 60,000 General Employee Shares 2016: 3 year term granted 22 Jul 2016: - 87

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Class		Ordinary
Number acquired		13,723
Number disposed
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil
No. of securities held after change		Ordinary Shares Direct: 352,146 Indirect: ..32,079 Unvested Share/Rights Grants: 2013 Series Performance Rights 2013:  4 year term, granted 7 May 2013, 3 year measurement period commencing 7 May 2014: - 65,000  4 year term, granted 7 May 2013, 4 year measurement period commencing 7 May 2013: - 65,000 2014 Series Deferred Shares Rights 2014:  3 year term granted 7 May 2014: - 58,000 Performance Rights 2014:  4 year term, granted 7 May 2014, 3 year measurement period commencing 7 May 2015: - 63,000  4 year term, granted 7 May 2014, 4 year measurement period commencing 7 May 2014: - 63,000 2015 Series Deferred Shares Rights 2015:  3 year term granted 7 May 2015: - 55,000 Performance Rights 2015:  4 year term, granted 7 May 2015, 3 year measurement period commencing 7 May 2016: - 60,000  4 year term, granted 7 May 2015, 4 year measurement period commencing 7 May 2015: - 60,000 2016 Series Deferred Shares Rights 2016:  3 year term granted 7 May 2016: - 60,000 Performance Rights 2016:  4 year term, granted 7 May 2016, 3 year measurement period commencing 1 Jan 2017: - 60,000  4 year term, granted 7 May 2016, 4 year measurement period commencing 1 Jan 2016: - 60,000 General Employee Shares 2016: 3 year term granted 22 Jul 2016:-87

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Further vesting on retest of Performance Rights Series 45 – 3,040, taking total vesting to 100%. Further vesting on retest of Performance Rights Series 46 – 10,683, taking total vesting to 84%. Vesting occurred on 3 March 2017 following end of the full year results trading blackout implemented under IRESS’ Employee ShareTradingPlan.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written **clearance was required? **	No
If so, was prior written clearance provided to allow the trade to proceed **during this period? **	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011